Craft BioSolutions provides a modular biomanufacturing platform that combines standardized hardware units with an integrated software suite to speed up development and scale-up of cell and protein therapeutics. The plug‑and‑play design and unified data acquisition tools enable biotech firms and CMOs to move from pilot to commercial production with lower capital costs and streamlined validation.
Funding
Funding not disclosed
Founders
Product
Problem
Biotech firms often face lengthy development cycles and high capital costs when scaling up production of cell and protein therapeutics, due to fragmented equipment, custom engineering, and complex process validation.
Solution
Craft BioSolutions offers a modular biomanufacturing platform that combines standardized hardware units with an integrated software suite to accelerate process development and scale biologics production. The platform’s plug‑and‑play design allows users to add or reconfigure modules as production needs change, reducing the time required to move from pilot to commercial scale. Built‑in data acquisition and control software streamlines validation, monitoring, and optimization, helping companies bring therapies to market faster while lowering upfront capital expenditures.
Target Audience
Primary customers are biotech companies and contract manufacturing organizations developing cell‑based or protein‑based therapeutics that require flexible, cost‑effective scale‑up capabilities.
Features
- Interchangeable bioreactor and downstream processing modules that can be rapidly assembled or expanded
- Unified software layer for real‑time process monitoring, control, and data analytics across all hardware components
- Standardized interfaces and connectors that eliminate custom integration effort
- Scalable architecture supporting production volumes from gram‑scale research to multi‑kilogram commercial batches
- Pre‑validated, GMP‑compatible hardware designs to accelerate regulatory approval